Viva BioInnovator operates as the investment division of Viva Biotech Holdings, focusing on identifying and supporting early-stage biotech companies through investment and incubation.

Viva BioInnovator

AceLink Therapeutics is involved in drug development, focusing on glycolipid biology and rare genetic diseases. The company collaborates with contract research organizations and academic leaders to transform scientific discoveries into therapies.

AceLink Therapeutics

Arthrosi Therapeutics is a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney disease. The company is self-described as working to create a people-centered environment.

Arthrosi Therapeutics, Inc.

Domain Therapeutics develops innovative treatments targeting GPCR mediated immunosuppression to improve clinical outcomes in cancer therapy, self-described as a unique GPCR company in Immuno-Oncology.

Domain Therapeutics

Viva BioInnovator | 696 followers on LinkedIn. As an investor, incubator, and partner, we work with some of the world&#39;s brightest minds to help discover novel drugs. | Viva BioInnovator (VBI) is the specialized investment and incubation division of Viva Biotech Holdings. We focus on the initial creation and development of biotech startups across all indications and drug types. During the early stages of drug discovery, we can nurture and accelerate a startup&#39;s growth from idea to clinical program.

Metric
Company Name	Viva BioInnovator	AceLink Therapeutics	Arthrosi Therapeutics, Inc.	Domain Therapeutics
Symbol
MSH ID	COM:VIVABIOINNOVATOR	COM:ACELINKTHERAPEUTICS	COM:ARTHROSI	COM:DOMAINTHERAPEUTICS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Biotechnology	Biotechnology	Biotechnology
Country	HK	US	US	FR
Stage		Venture Round	Venture Round
Employee Count
Website	vivabioinnovator.com	acelinktherapeutics.com/home	arthrosi.com	domaintherapeutics.com
LinkedIn	viva-bioinnovator	acelink-therapeutics	arthrosi-therapeutics-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	176	1
Web Traffic Growth	-0.72	-1.00
Valuation
Raised Capital			7M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VIVA

COM:VIVABIOINNOVATOR

Viva BioInnovator

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue